103 related articles for article (PubMed ID: 2867187)
21. Analgesia induced by 5-hydroxytryptamine receptor agonists is blocked or reversed by noradrenaline-depletion in rats.
Post C; Minor BG; Davies M; Archer T
Brain Res; 1986 Jan; 363(1):18-27. PubMed ID: 3484988
[TBL] [Abstract][Full Text] [Related]
22. Possible mechanism of 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in DRN lesioned rats.
Blackburn TP; Cox B; Heapy CG; Lee TF
Pharmacol Biochem Behav; 1982 Jan; 16(1):7-11. PubMed ID: 7058215
[TBL] [Abstract][Full Text] [Related]
23. The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity.
Reimann W; Schneider F
Gen Pharmacol; 1993 Mar; 24(2):449-53. PubMed ID: 8482527
[TBL] [Abstract][Full Text] [Related]
24. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
25. Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP.
Sills MA; Lucki I; Frazer A
Life Sci; 1985 Jul; 36(26):2463-9. PubMed ID: 4010463
[TBL] [Abstract][Full Text] [Related]
26. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
Eide PK; Hole K; Berge OG; Broch OJ
Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
[TBL] [Abstract][Full Text] [Related]
27. Blockade and reversal of 5-methoxy-N,N-dimethyltryptamine-induced analgesia following noradrenaline depletion.
Archer T; Minor BG; Post C
Brain Res; 1985 Apr; 333(1):55-61. PubMed ID: 3158373
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of prolactin release by stimulation of presynaptic serotonin autoreceptors.
Clemens JA; Roush ME
Life Sci; 1982 Dec; 31(23):2641-6. PubMed ID: 7154858
[TBL] [Abstract][Full Text] [Related]
29. Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy.
Wada Y; Hasegawa H; Nakamura M; Yamaguchi N
Neurosci Lett; 1992 Apr; 138(1):115-8. PubMed ID: 1407649
[TBL] [Abstract][Full Text] [Related]
30. 5-Methoxy-N,N-dimethyltryptamine: spinal cord and brainstem mediation of excitatory effects on acoustic startle.
Davis M; Astrachan DI; Gendelman PM; Gendelman DS
Psychopharmacology (Berl); 1980; 70(2):123-30. PubMed ID: 6776570
[TBL] [Abstract][Full Text] [Related]
31. Nociception is enhanced after low doses and reduced after high doses of the serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine.
Berge OG; Hole K; Dahle H
Neurosci Lett; 1980 Sep; 19(2):219-23. PubMed ID: 6302598
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of 5-methoxy-N,N-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine.
Berge OG; Chacho D; Hole K
Eur J Pharmacol; 1983 Jun; 90(2-3):293-6. PubMed ID: 6873188
[TBL] [Abstract][Full Text] [Related]
33. Ejaculations induced by p-chloroamphetamine in the rat.
Rènyi L
Neuropharmacology; 1985 Aug; 24(8):697-704. PubMed ID: 3837857
[TBL] [Abstract][Full Text] [Related]
34. Serotonergic involvement in phencyclidine-induced behaviors.
Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
[TBL] [Abstract][Full Text] [Related]
35. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants.
Lucki I; Frazer A
Psychopharmacology (Berl); 1982; 77(3):205-11. PubMed ID: 6812141
[TBL] [Abstract][Full Text] [Related]
36. 5-Methoxy-N,N-dimethyltryptamine-induced analgesia is blocked by alpha-adrenoceptor antagonists in rats.
Archer T; Danysz W; Jonsson G; Minor BG; Post C
Br J Pharmacol; 1986 Oct; 89(2):293-8. PubMed ID: 2877697
[TBL] [Abstract][Full Text] [Related]
37. Antidepressants and serotonergic neurotransmission: an integrative review.
Willner P
Psychopharmacology (Berl); 1985; 85(4):387-404. PubMed ID: 2410942
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic properties of serotonergic agents and antidepressant drugs.
Fuller RW
J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
[TBL] [Abstract][Full Text] [Related]
39. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
Yamazaki J; Fukuda H; Nagao T; Ono H
Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651
[TBL] [Abstract][Full Text] [Related]
40. Intrathecal noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced antinociception abolished by intrathecal 6-hydroxydopamine.
Minor BG; Persson ML; Post C; Jonsson G; Archer T
J Neural Transm; 1988; 72(2):107-20. PubMed ID: 3133452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
